These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11465073)

  • 1. Antitumor potential and possible targets of phenothiazine-related compounds.
    Motohashi N; Kawase M; Saito S; Sakagami H
    Curr Drug Targets; 2000 Nov; 1(3):237-45. PubMed ID: 11465073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
    Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
    Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
    Motohashi N; Sakagami H; Kamata K; Yamamoto Y
    Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic potential of phenothiazines.
    Motohashi N; Kawase M; Satoh K; Sakagami H
    Curr Drug Targets; 2006 Sep; 7(9):1055-66. PubMed ID: 17017885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines.
    Satoh K; Sakagami H; Kurihara T; Motohashi N
    Anticancer Res; 1997; 17(4A):2465-9. PubMed ID: 9252664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse biological activities displayed by phenothiazines, benzo[a]phenothiazines and benz[c]acridins (review).
    Molnár J; Sakagami H; Motohashi N
    Anticancer Res; 1993; 13(4):1019-25. PubMed ID: 8352520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors.
    Gil-Ad I; Shtaif B; Levkovitz Y; Dayag M; Zeldich E; Weizman A
    J Mol Neurosci; 2004; 22(3):189-98. PubMed ID: 14997012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between biological activity and dipole moment in benzo[a]phenothiazines.
    Motohashi N; Kurihara T; Yamanaka W; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(5A):3431-5. PubMed ID: 9413182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
    Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of benzo[a]phenothiazines on natural killer cell activity of human peripheral blood mononuclear cells.
    Petri IB; Szekeres E; Berek I; Molnár J; Sakagami H; Motohashi N
    Anticancer Res; 1993; 13(6A):2273-5. PubMed ID: 8297145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of benzo[a]phenothiazines.
    Motohashi N; Kurihara T; Satoh K; Sakagami H; Mucsi I; Pusztai R; Szabó M; Molnár J
    Anticancer Res; 1999; 19(3A):1837-42. PubMed ID: 10470124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
    Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
    Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible Biological and Clinical Applications of Phenothiazines.
    Varga B; Csonka Á; Csonka A; Molnár J; Amaral L; Spengler G
    Anticancer Res; 2017 Nov; 37(11):5983-5993. PubMed ID: 29061777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New derivatives of phenothiazines with anticancer activities].
    Morak-Młodawska B; Jeleń M; Pluta K
    Pol Merkur Lekarski; 2009 Jun; 26(156):671-5. PubMed ID: 19711740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on phenothiazines: New microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents.
    Ghinet A; Moise IM; Rigo B; Homerin G; Farce A; Dubois J; Bîcu E
    Bioorg Med Chem; 2016 May; 24(10):2307-17. PubMed ID: 27073050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
    Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
    Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
    Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
    Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
    Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.